|
Volumn 32, Issue 5, 2005, Pages 641-644
|
A pilot study of weekly paclitaxel administration for patients with relapsed cervical cancer after heavy medication.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
CIMETIDINE;
DEXAMETHASONE;
DIPHENHYDRAMINE;
PACLITAXEL;
AGRANULOCYTOSIS;
ALOPECIA;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FEMALE;
HUMAN;
HYSTERECTOMY;
INTRAVENOUS DRUG ADMINISTRATION;
LYMPHADENECTOMY;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PILOT STUDY;
SURVIVAL RATE;
TUMOR RECURRENCE;
UTERINE CERVIX TUMOR;
AGRANULOCYTOSIS;
ALOPECIA;
ANTIEMETICS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CIMETIDINE;
COMBINED MODALITY THERAPY;
DEXAMETHASONE;
DIPHENHYDRAMINE;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
HYSTERECTOMY;
INFUSIONS, INTRAVENOUS;
LYMPH NODE EXCISION;
NEOPLASM RECURRENCE, LOCAL;
PACLITAXEL;
PILOT PROJECTS;
SURVIVAL RATE;
UTERINE CERVICAL NEOPLASMS;
|
EID: 19544362407
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|